Clinical Trials on Recurrent Acute Myeloid Leukemia in United Kingdom
Total 3420 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUntreated Adult Acute Myeloid LeukemiaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnUntreated Adult Acute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedClear Cell Renal Cell Carcinoma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent... and other conditionsUnited States, Germany
-
University of PennsylvaniaTerminatedRelapsed or Refractory Acute Myeloid LeukemiaUnited States
-
University Hospital Southampton NHS Foundation...Imperial College Healthcare NHS Trust; Royal Devon and Exeter NHS Foundation... and other collaboratorsCompletedLeukaemia (Acute) | Leukaemia (Chronic) | Leukaemia (Acute Myeloid) | Leukaemia (Acute Lymphoblastic) | Leukaemia (Acute Promyelocytic)United Kingdom
-
CelgeneAbbVieCompletedLeukemia, Myeloid, AcuteUnited States, Australia
-
AbbVieAstellas Pharma Inc; Genentech, Inc.CompletedAcute Myeloid Leukemia (AML)United States
-
BayerCompletedLeukemia, Myeloid, AcuteUnited States, Germany
-
Inmune Bio, Inc.TerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | AML | MDS-EBUnited Kingdom, Greece
-
Oryzon Genomics S.A.RecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryUnited States
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCActive, not recruitingAcute Myeloid Leukemia, in RelapseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Blasts More Than 20 Percent of Bone Marrow Nucleated Cells | Blasts More Than 20 Percent of Peripheral Blood White CellsUnited States
-
AbbVieTerminatedAcute Myeloid Leukemia (AML)United States
-
National Cancer Institute (NCI)TerminatedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia With KMT2A Rearrangement | Acute Myeloid Leukemia With NPM1 MutationUnited States
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, France, Italy, Korea, Republic of, Spain, United Kingdom, Australia, Canada, Germany, Netherlands, Portugal, Switzerland, Belgium, Sweden
-
AbbVieMerck Sharp & Dohme LLCTerminatedCancer - Acute Myeloid LeukemiaUnited States, Australia, Spain
-
Hoffmann-La RocheCompletedMyelogenous Leukemia, AcuteUnited States, Korea, Republic of, Australia, United Kingdom, Canada, France, Italy
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
M.D. Anderson Cancer CenterGlaxoSmithKlineNot yet recruiting
-
St. Jude Children's Research HospitalAbbVieRecruitingAcute Myeloid LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsRecruitingAcute Myeloid LeukemiaUnited States
-
Uma BorateRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteMinneamrita Therapeutics LLCTerminatedAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterSuspendedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalActive, not recruiting
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterPfizerCompletedAcute Myeloid LeukemiaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
ImmunityBio, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
PfizerCompletedLeukemia, Myeloid, AcuteUnited States
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedAcute Myeloid LeukemiaUnited States
-
University of FloridaOregon Health and Science University; The Leukemia and Lymphoma Society; Cellworks...Completed
-
University of ChicagoNational Cancer Institute (NCI)CompletedAcute Myeloid LeukemiaUnited States
-
University of Colorado, DenverCelgeneCompletedAcute Myeloid LeukemiaUnited States
-
University of FloridaNovartis PharmaceuticalsWithdrawnAcute Myeloid LeukemiaUnited States
-
Bruno C. MedeirosSchering-PloughCompletedLeukemia, MyeloidUnited States
-
Novartis PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
AbbVieRoche-GenentechActive, not recruitingAcute Myeloid Leukemia (AML)United States, Australia, Canada, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedClear Cell Renal Cell Carcinoma | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Lymphoblastic Lymphoma | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute... and other conditionsUnited States, Germany, Italy
-
Janssen Research & Development, LLCRecruitingLeukemia, Myeloid, AcuteUnited States, Germany, Italy, France, Australia, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Antonio M Jimenez JimenezAbbVieNot yet recruiting
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid LeukemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of HealthRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
Brian JonasNational Cancer Institute (NCI); GlycoMimetics IncorporatedRecruitingUproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid LeukemiaAcute Myeloid LeukemiaUnited States